IFNB1 and gastric cancer: In addition, MK1775 treatment significantly increased the expression of proinflammatory cytokines such as CCL20, CXCL10, and IFN-β in MUS81 knockdown cells, but increased expression modestly in parental gastric cancer cells (Fig. 4g–i).